Realizing the potential of plasma genotyping in an age of genotype-directed therapies.
暂无分享,去创建一个
C. Paweletz | D. Solit | D. Camidge | J. Luke | G. Oxnard | B. Johnson | J. Heymach
[1] 大堀 理,et al. Memorial Sloan-Kettering Cancer Center , 2020, Definitions.
[2] L. Diaz,et al. Liquid biopsies: genotyping circulating tumor DNA. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Paweletz,et al. Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA , 2014, Clinical Cancer Research.
[4] Jorge S. Reis-Filho,et al. Going with the Flow: From Circulating Tumor Cells to DNA , 2013, Science Translational Medicine.
[5] G. Zhu,et al. High T790M detection rate in TKI-naive NSCLC with EGFR sensitive mutation: truth or artifact? , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] F. Nicolantonio,et al. Liquid biopsy: monitoring cancer-genetics in the blood , 2013, Nature Reviews Clinical Oncology.
[7] Jorge S. Reis-Filho,et al. Circulating tumour cells and cell-free DNA as tools for managing breast cancer , 2013, Nature Reviews Clinical Oncology.
[8] Andrea Bertotti,et al. Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer. , 2013, Cancer discovery.
[9] N. Rosenfeld,et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA , 2013, Nature.
[10] Carlos Caldas,et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.
[11] G. Parmigiani,et al. Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing , 2012, Science Translational Medicine.
[12] Massimo Cristofanilli,et al. Considerations in the development of circulating tumor cell technology for clinical use , 2012, Journal of Translational Medicine.
[13] Enzo Medico,et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer , 2012, Nature.
[14] Johannes G. Reiter,et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.
[15] N. Rosenfeld,et al. Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA , 2012, Science Translational Medicine.
[16] Ben H. Park,et al. Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood , 2012, Clinical Cancer Research.
[17] A. Miller. New data on prostate-cancer mortality after PSA screening. , 2012, The New England journal of medicine.
[18] Koichi Goto,et al. Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[19] Hyae-Young Kim,et al. Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy , 2011, Clinical Cancer Research.
[20] Jin Li,et al. Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations , 2010, Nucleic Acids Res..
[21] V. de Giorgi,et al. Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[22] F. Cianchi,et al. The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer. , 2010, The Journal of molecular diagnostics : JMD.
[23] David N Louis,et al. Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine , 2010, EMBO molecular medicine.
[24] M. Ranson,et al. Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer , 2010, Breast Cancer Research and Treatment.
[25] L. Diaz,et al. Analysis of circulating tumor DNA to confirm somatic KRAS mutations. , 2009, Journal of the National Cancer Institute.
[26] F. Monzon. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing , 2009 .
[27] Mehmet Toner,et al. Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.
[28] J. Wagner. Strategic approach to fit-for-purpose biomarkers in drug development. , 2008, Annual review of pharmacology and toxicology.
[29] S. Goodman,et al. Circulating mutant DNA to assess tumor dynamics , 2008, Nature Medicine.
[30] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[31] K. Nishio,et al. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non‐small cell lung cancer patients , 2006, Cancer science.
[32] Andrew D Griffiths,et al. Amplification of complex gene libraries by emulsion PCR , 2006, Nature Methods.
[33] K. Nishio,et al. Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer , 2006, Clinical Cancer Research.
[34] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[35] R. Riesenberg,et al. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. , 2000, The Journal of urology.
[36] A. Weiss,et al. Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Butler,et al. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. , 1993, Cancer research.
[38] F. Sanger,et al. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. , 1975, Journal of molecular biology.